Food and Drug Administration confirms Fresh Amgen drug for protection of migraines
Amgen won U.S. FDA consent on Thursday for the premier drug to protect migraine headaches in adults. The drug, Aimovig, that is given every 30 days by self-injection, going to have a list price of $six,900 a year, or $575 a 30 days, the Inc. said. Any sales or rebates going to depend on negotiations by health plans, Amgen spokeswoman Kristen Davis said. Some Wall Street analysts had Guessed Amgen to price Aimovig as high as $ten,000 a year. Amgen, that going to market Aimovig in copartnership by Novartis, said the drug's price "reflects the Price it brings to patients & community." Lake Travis ISD confirms mandatory drug Analyzing of proven students The Lake Travis school board confirmed a mandatory drug Analyzing policy Wednesday night for proven middle & high school students. FROM THE ARCHIVES: San Marcos school territory stops Analyzing students for drugsSchool-sponsored competitive extracurricular activities involve University Interscholastic League spons